Hector - You are correct, but I refer to number of traders, speculators, and money flow on the USA stock exchange as opposed to actual market for cancer product sales.
Though most of you will disagree... PRR and DNDN is being valued on speculation aka rampant buying... Trying to justify a market cap based on "Sales" is inappropriate because you dont have sales or profit to refer to... In either case.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
-0.005(1.92%) |
Mkt cap ! $372.3M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 27.5¢ | 25.5¢ | $1.276M | 4.866M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 22343 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 193000 | 3 |
View Market Depth
| Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
| IMM (ASX) Chart |